Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:702-707
Published online before print September 13, 2004, doi: 10.1161/01.HYP.0000143483.66701.ec
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/5/702    most recent
01.HYP.0000143483.66701.ecv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serrano, N. C.
Right arrow Articles by López-Jaramillo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serrano, N. C.
Right arrow Articles by López-Jaramillo, P.
Related Collections
Right arrow Risk Factors
Right arrow Other hypertension
Right arrow Genetics of cardiovascular disease
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2004;44:702.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Endothelial NO Synthase Genotype and Risk of Preeclampsia

A Multicenter Case-Control Study

Norma C. Serrano; Juan P. Casas; Luis A. Díaz; Carolina Páez; Clara M. Mesa; Rodrigo Cifuentes; Alvaro Monterrosa; Alejandro Bautista; Emma Hawe; Aroon D. Hingorani; Patrick Vallance; Patricio López-Jaramillo

From the Universidad Autónoma de Bucaramanga (N.C.S., L.A.D., C.P.), Colombia; Centre for Clinical Pharmacology (J.P.C., A.D.H., P.V.), Department of Medicine, BHF Laboratories at University College London (UCL), United Kingdom; Instituto de Ciencias de la Salud, Colombia (C.M.M.); Universidad del Valle (R.C.), Colombia; Universidad de Cartagena, Colombia (A.M.); Universidad Nacional de Colombia (A.B.), Colombia; Centre for Cardiovascular Genetics (E.H.), Department of Medicine, British Heart Foundation Laboratories at UCL; Instituto Colombiano de Investigaciones Biomédicas (P.L.-J.), Colombia; and Fundación Cardiovascular del Oriente Colombiano, Colombia (P.L.-J.).

Correspondence to Dr Norma C. Serrano, Genetics and Human Biology Laboratory, Department of Medicine at Universidad Autónoma de Bucaramanga, Colombia, Campus el Bosque, Calle 157 No. 19-55 Cañaveral Parque, Colombia. E-mail nserrano{at}unab.edu.co

Polymorphisms in the endothelial NO synthase (eNOS) gene have been evaluated as risk factors for preeclampsia. However, data from small studies are conflicting. We assessed whether eNOS genotypes alter the risk of preeclampsia in a population in which the incidence of this disorder is high. A total of 844 young pregnant women (322 preeclamptic and 522 controls) were recruited from 5 cities. Genotyping for the Glu298Asp, intron-4 and –786T->C polymorphisms in the eNOS gene was conducted. Multivariate odds ratios (ORs) were obtained to estimate the association of individual polymorphisms and haplotypes with preeclampsia risk. No increase in the risk of preeclampsia for the intron-4 or –786T->C polymorphisms was observed under any model of inheritance. In contrast, in women homozygous for the Asp298 allele, the adjusted OR for preeclampsia was 4.60 (95% confidence interval [CI], 1.73 to 12.22) compared with carriers of the Glu298 allele. After a multivariate analysis, carriage of the "Asp298–786C-4b" haplotype was also associated with increased risk of preeclampsia (OR, 2.11 [95% CI, 1.33 to 3.34]) compared with carriers of the "Glu298–786T-4b" haplotype. The eNOS Glu298Asp polymorphism and the Asp298–786C-4b haplotype are risk factors for preeclampsia.


Key Words: preeclampsia • nitric oxide synthase • polymorphism • haplotypes • case-control studies




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
P. Lopez-Jaramillo, W. D. Arenas, R. G. Garcia, M. Y. Rincon, and M. Lopez
Review: The role of the L-arginine-nitric oxide pathway in preeclampsia
Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 261 - 275.
[Abstract] [PDF]


Home page
HypertensionHome page
B. D. LaMarca, J. Gilbert, and J. P. Granger
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
Hypertension, April 1, 2008; 51(4): 982 - 988.
[Full Text] [PDF]


Home page
HypertensionHome page
A. M. Germain, M. C. Romanik, I. Guerra, S. Solari, M. S. Reyes, R. J. Johnson, K. Price, S. A. Karumanchi, and G. Valdes
Endothelial Dysfunction: A Link Among Preeclampsia, Recurrent Pregnancy Loss, and Future Cardiovascular Events?
Hypertension, January 1, 2007; 49(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Kulandavelu, D. Qu, and S. L. Adamson
Cardiovascular Function in Mice During Normal Pregnancy and in the Absence of Endothelial NO Synthase
Hypertension, June 1, 2006; 47(6): 1175 - 1182.
[Abstract] [Full Text] [PDF]